Yonhap Infomax NewsSep 24, 2025
IGIS Asia, the overseas arm of IGIS Asset Management, is entering the healthcare real estate market by investing in stem cell firm MonitCell and planning a new fund, targeting Asia’s booming medical tourism sector.
#YonhapInfomax #IGISAsia #MonitCell #HealthcareRealEstate #MedicalTourism #StemCellTechnology #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=83336
IGIS Asia Reshapes Healthcare Real Estate Landscape with Investment in Stem Cell Firm

IGIS Asia, the overseas arm of IGIS Asset Management, is entering the healthcare real estate market by investing in stem cell firm MonitCell and planning a new fund, targeting Asia’s booming medical tourism sector.

Yonhap Infomax
KeyUpIdeasJul 9, 2025

✔️ BioForge: On-Demand 3D Bioprinting of Human Organs & Tissues

✨A breakthrough medical technology that allows hospitals and research centers to 3D print fully functional human organs and tissues on demand, eliminating donor shortages and saving millions of lives.

#3DBioprinting #RegenerativeMedicine #OnDemandOrganPrinting #HealthcareInnovation #StemCellTechnology